Meeder Asset Management Inc Axogen, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $1,869 - $2,591	198 New	198 $1,000
Q3 2021 Nov 08, 2021	SELL	$15.23 - $21.72 $41,242 - $58,817	-2,708 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$17.8 - $23.5 $29,868 - $39,433	-1,678 Reduced 38.26%	2,708 $59,000
Q1 2021 Apr 28, 2021	BUY	$17.18 - $22.6 $75,351 - $99,123	4,386 New	4,386 $90,000
Q3 2018 Nov 02, 2018	SELL	$34.05 - $55.9 $82,639 - $135,669	-2,427 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$36.15 - $52.5 $78,445 - $113,925	2,170 Added 844.36%	2,427 $0
Q1 2018 May 03, 2018	BUY	$24.4 - $40.25 $5,856 - $9,660	240 Added 1411.76%	257 $10,000
Q4 2017 Feb 02, 2018	BUY	$18.5 - $28.6 $314 - $486	17	17 $0

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $697M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.